About us
MonTa Biosciences is a clinical stage biotech company located in the science park of The Danish Technical University in Kgs. Lyngby, North of Copenhagen.
Our technology encompass a novel cancer immunotherapy approach using LNPs to stimulate immune cells to migrate into tumor tissue leading to tumor cell killing within hours. The LNPs contain a small molecule TLR7 agonist that due to the formulation show a novel approach to stimulate both innate and adaptive immune responses to suppress tumor growth and metastatic disease.
MonTa Biosciences is running our phase I clinical study and have completed the dose escalation study and are planning the dose escalation study also called phase IB.
